Kathryn Evans

3.0k total citations
52 papers, 1.7k citations indexed

About

Kathryn Evans is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Hematology. According to data from OpenAlex, Kathryn Evans has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 14 papers in Oncology and 14 papers in Hematology. Recurrent topics in Kathryn Evans's work include Acute Lymphoblastic Leukemia research (29 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (7 papers). Kathryn Evans is often cited by papers focused on Acute Lymphoblastic Leukemia research (29 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (7 papers). Kathryn Evans collaborates with scholars based in Australia, United States and United Kingdom. Kathryn Evans's co-authors include Rita A. Fuchs, Ronald E. See, Jordan M. Case, Christopher C. Ledford, Richard B. Lock, Malcolm A. Smith, Peter J. Houghton, Hernán Carol, Jennifer Richmond and Raushan T. Kurmasheva and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Blood.

In The Last Decade

Kathryn Evans

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Evans Australia 19 857 547 476 306 305 52 1.7k
Pamela S. Hunt United States 25 464 0.5× 500 0.9× 378 0.8× 158 0.5× 23 0.1× 57 2.2k
Marie‐Christine Birling France 25 477 0.6× 1.0k 1.9× 124 0.3× 86 0.3× 104 0.3× 61 1.8k
Ilse Bartke Germany 13 1.1k 1.3× 716 1.3× 117 0.2× 278 0.9× 38 0.1× 15 2.5k
Enrica Audero Italy 17 378 0.4× 912 1.7× 120 0.3× 228 0.7× 26 0.1× 21 1.7k
Stefania Fasano Italy 22 867 1.0× 1.0k 1.9× 226 0.5× 66 0.2× 46 0.2× 31 2.0k
Samuel A. Rose United States 4 261 0.3× 602 1.1× 179 0.4× 141 0.5× 39 0.1× 5 1.8k
Jan‐Hermen Dannenberg Netherlands 18 326 0.4× 2.5k 4.7× 137 0.3× 868 2.8× 51 0.2× 20 3.3k
Katherine Tooley United States 5 262 0.3× 493 0.9× 179 0.4× 133 0.4× 39 0.1× 7 1.8k
Thaddeus J. Unger United States 15 178 0.2× 775 1.4× 65 0.1× 306 1.0× 44 0.1× 17 1.4k
Ahmet Arslan United States 21 182 0.2× 573 1.0× 277 0.6× 188 0.6× 19 0.1× 52 1.5k

Countries citing papers authored by Kathryn Evans

Since Specialization
Citations

This map shows the geographic impact of Kathryn Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Evans more than expected).

Fields of papers citing papers by Kathryn Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Evans. The network helps show where Kathryn Evans may publish in the future.

Co-authorship network of co-authors of Kathryn Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Evans. A scholar is included among the top collaborators of Kathryn Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Evans. Kathryn Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tremblay, Cédric S., Jacqueline Boyle, Katharina Haigh, et al.. (2023). STAT5 activation promotes progression and chemotherapy-resistance in early T-cell precursor acute lymphoblastic leukemia. Blood. 142(1). 40–40. 10 indexed citations
3.
Evans, Kathryn, Eric J. Earley, Christopher M. Smith, et al.. (2023). In vivo activity of the dual SYK/FLT3 inhibitor TAK‐659 against pediatric acute lymphoblastic leukemia xenografts. Pediatric Blood & Cancer. 70(9). e30503–e30503. 2 indexed citations
4.
Evans, Kathryn, et al.. (2023). Perpetual Protection for Atlanta’s High-Quality Forested Land in the City. 13(1). 1 indexed citations
5.
Evans, Kathryn, Christopher M. Smith, Eric J. Earley, et al.. (2023). In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts. Pediatric Blood & Cancer. 70(8). e30398–e30398. 4 indexed citations
6.
Tremblay, Cédric S., Hannah McCalmont, Véronique Litalien, et al.. (2020). Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells. Nature Communications. 11(1). 6211–6211. 23 indexed citations
7.
Bendak, Katerina, Hernán Carol, Kathryn Evans, et al.. (2020). Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia. British Journal of Cancer. 123(5). 742–751. 2 indexed citations
8.
McCalmont, Hannah, Kathryn Evans, Chelsea Mayoh, et al.. (2019). Preclinical activity of the antibody‐drug conjugate denintuzumab mafodotin (SGN‐CD19A) against pediatric acute lymphoblastic leukemia xenografts. Pediatric Blood & Cancer. 66(8). e27765–e27765. 22 indexed citations
9.
Jing, Duohui, Yizhou Huang, Xiaoyun Liu, et al.. (2018). Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia. Cancer Cell. 34(6). 906–921.e8. 48 indexed citations
10.
Richmond, Jennifer, Kathryn Evans, Hernán Carol, et al.. (2017). Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL. Clinical Cancer Research. 23(14). 3744–3755. 17 indexed citations
11.
Richmond, Jennifer, Alissa K. Robbins, Kathryn Evans, et al.. (2016). Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant. Cancer Research. 76(15). 4579–4591. 18 indexed citations
12.
Khaw, Seong Lin, Santi Suryani, Kathryn Evans, et al.. (2016). Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia. Blood. 128(10). 1382–1395. 112 indexed citations
13.
Churchman, Michelle L., Kathryn Evans, Jennifer Richmond, et al.. (2016). Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL. JCI Insight. 1(4). 44 indexed citations
14.
Carol, Hernán, Kathryn Evans, Jennifer Richmond, et al.. (2016). A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program. Leukemia. 30(11). 2133–2141. 36 indexed citations
15.
Richmond, Jennifer, Hernán Carol, Kathryn Evans, et al.. (2015). Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL -Rearranged Acute Lymphoblastic Leukemia. Clinical Cancer Research. 21(6). 1395–1405. 41 indexed citations
16.
Suryani, Santi, Richard C. Harvey, Hernán Carol, et al.. (2014). Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics. 14(2). 364–374. 43 indexed citations
17.
Tursky, Melinda L., Dominik Beck, Julie A.I. Thoms, et al.. (2014). Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias. Leukemia. 29(4). 819–827. 17 indexed citations
18.
Carol, Hernán, Barbara Szymanska, Kathryn Evans, et al.. (2013). The Anti-CD19 Antibody–Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia. Clinical Cancer Research. 19(7). 1795–1805. 57 indexed citations
19.
20.
Evans, Kathryn. (2001). Rethinking Self-Assessment as a Tool for Response. Teaching English in the Two-Year College. 28(3). 293–301. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela S. Hunt Breakdown of academic impact, for papers by Marie‐Christine Birling Breakdown of academic impact, for papers by Ilse Bartke Breakdown of academic impact, for papers by Enrica Audero Breakdown of academic impact, for papers by Stefania Fasano Breakdown of academic impact, for papers by Samuel A. Rose Breakdown of academic impact, for papers by Jan‐Hermen Dannenberg Breakdown of academic impact, for papers by Katherine Tooley Breakdown of academic impact, for papers by Thaddeus J. Unger Breakdown of academic impact, for papers by Ahmet Arslan
Rankless by CCL
2026